Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New arm-measuring device could help breast cancer patients spot lymphedema early

NCT ID NCT07154771

Knowledge-focused Sponsor: Saglik Bilimleri Universitesi Gulhane Tip Fakultesi Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study is testing a newly developed arm circumference measurement device for patients who may develop lymphedema after breast cancer surgery. Researchers want to see if the device is more accurate, faster, and easier to use than the traditional tape measure. The study involves 35 patients and nurses who will take measurements using both methods. The goal is to improve monitoring of arm swelling, which is a common side effect of breast cancer treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
arm circumference measurement device
What this could lead to
If successful, this device could make it easier for patients and nurses to monitor arm swelling after breast cancer surgery, potentially improving early detection of lymphedema.
What could go wrong
This is a small, early-stage usability study with only 35 participants, so results may not apply to all patients. The device may not prove more accurate or practical than a simple tape measure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 35 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Nov 2025

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Nurses: -Currently working in General Surgery or Surgical Oncology clinics Patients: * Aged 18 years or older * Newly diagnosed with breast cancer confirmed by histopathology * Planned to undergo radical mastectomy, modified radical mastectomy, or breast-conserving surgery * Scheduled for axillary lymph node dissection (at least two lymph nodes to be dissected) * Able to understand information related to circumference measurement and perform the required skills Exclusion Criteria: Patients: * Patients who have undergone bilateral lymph node dissection * Patients with a prior diagnosis and treatment for breast cancer (surgery, chemotherapy, etc.)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm lymphedema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer Breast surgery Lymphedema

Contacts and locations

Locations

  • Gülhane Training and Research Hospital, University of Health Sciences

    Ankara, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.